Phase 1 clinical trials will test this nanotechnology-enabled vaccine that is intended to help people stop smoking and help prevent relapse.
http://www.masshightech.com/stories/2011/11/21/daily10-Selecta-brings-its-first-synthetic-nano-vaccine-to-human-trials.html